Soleno Therapeutics Inc

NASDAQ:SLNO   11:16:28 AM EDT
0.17
0.00 (-1.12%)
Earnings Announcements

Soleno Therapeutics Provides Corporate Update And Reports Fourth Quarter And Full-Year 2021 Financial Results

Published: 03/31/2022 20:31 GMT
Soleno Therapeutics Inc (SLNO) - Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-year 2021 Financial Results.
Q4 Loss per Share $0.04.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.